Pages that link to "Q48590390"

The following pages link to Increased S100β in the cerebrospinal fluid of patients with frontotemporal dementia (Q48590390):

Displaying 25 items.

• Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease (Q28366081) (← links)
• Colchicine-induced cytoskeletal collapse and apoptosis in N-18 neuroblastoma cultures is rapidly reversed by applied S-100beta (Q33182368) (← links)
• Serum levels of S100B and NSE proteins in Alzheimer's disease patients (Q33705590) (← links)
• Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients. (Q34577625) (← links)
• Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease (Q35114490) (← links)
• The Serum Concentration of the Calcium Binding Protein S100B is Positively Associated with Cognitive Performance in Older Adults (Q37205890) (← links)
• Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases (Q37206262) (← links)
• The roles of TNF in brain dysfunction and disease (Q37784863) (← links)
• S100B protein in neurodegenerative disorders (Q37837904) (← links)
• Proteomics as an innovative tool to investigate frontotemporal disorders (Q38802995) (← links)
• S100beta protein expression: gender- and age-related daily changes. (Q39307755) (← links)
• Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer's disease. (Q39428145) (← links)
• Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis. (Q40458885) (← links)
• S100 B: A new concept in neurocritical care (Q41122605) (← links)
• Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease (Q43592525) (← links)
• Cerebrospinal fluid S-100 protein levels in neurological pathologies (Q47425911) (← links)
• Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease (Q48417985) (← links)
• Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease (Q48771318) (← links)
• Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies (Q49161817) (← links)
• Elevated S100B and Neuron Specific Enolase Levels in Patients with Migraine-without Aura: Evidence for Neurodegeneration? (Q52607697) (← links)
• TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease. (Q53278207) (← links)
• Research goals in progressive supranuclear palsy (Q57089159) (← links)
• S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702 (Q73505841) (← links)
• [Level of S-100 and neuron-specific enolase in cerebrospinal fluid from subjects with neurological pathologies] (Q73626813) (← links)
• Genealogy of the neurodegenerative diseases based on a meta-analysis of age-stratified incidence data (Q101216882) (← links)